XPPen Unveils Stunning New Artist 12 3rd with X-Dial Shortcut Keys and Upgraded X4 Smart Chip Stylus
LOS ANGELES, Oct. 20, 2025 /PRNewswire/ -- XPPen today unveiled the groundbreaking Artist…
TUMI INVITES YOU TO “GIFT JOY” THIS HOLIDAY SEASON
Discover timeless gifts that celebrate craftsmanship, purpose, and the beauty of detail.…
NYSE Content Advisory: Pre-Market Update + 2025 3M Young Scientist Rings Opening Bell
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- The New York Stock Exchange…
ST Engineering iDirect Announces General Availability of Intuition Ground System
Cloud-native architecture and high-density baseband processing improves operational efficiency, performance and TCO HERNDON,…
KuCard and Plaza Premium Lounge Announce Partnership to Advance Crypto Integration in Travel Services
PROVIDENCIALES, Turks and Caicos Islands, Oct. 20, 2025 /PRNewswire/ -- KuCard, a Visa…
Dubai advances position as Middle East, Africa and South Asia’s leading global financial centre
DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ -- Dubai continues to advance its…
Fruit Attraction 2025 Strengthens Its Global Leadership with a Record 121,137 Trade Professionals
MADRID, Oct. 20, 2025 /PRNewswire/ -- Fruit Attraction 2025, organised by IFEMA…
IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab…
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha…
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
